(MNDY) Monday.Com - Overview
Exchange: NASDAQ •
Country: Israel •
Currency: USD •
Type: Common Stock •
ISIN: IL0011762130
Stock: Work OS, Work Management, CRM, Software Development, Service Desk
Total Rating 32
Risk 45
Buy Signal -0.56
| Risk 5d forecast | |
|---|---|
| Volatility | 69.1% |
| Relative Tail Risk | -8.74% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -1.69 |
| Alpha | -100.18 |
| Character TTM | |
|---|---|
| Beta | 1.589 |
| Beta Downside | 2.040 |
| Drawdowns 3y | |
|---|---|
| Max DD | 78.62% |
| CAGR/Max DD | -0.23 |
EPS (Earnings per Share)
Revenue
Risks
Technicals:
choppy
Description: MNDY Monday.Com March 04, 2026
monday.com Ltd. (MNDY) develops and provides cloud-based software applications globally. Their core offering, Work OS, is a modular platform for various work management tools.
The company offers specialized products like monday work management for team collaboration, monday CRM for sales cycle tracking, monday dev for software development workflows, and monday service for customer service operations. These offerings reflect the broader trend in the software industry towards integrated, cloud-based solutions for diverse business functions.
MNDYs business model centers on providing a Work Operating System that can be customized for different organizational needs, serving businesses, educational institutions, and government entities. This aligns with the Software as a Service (SaaS) model, characterized by subscription-based access to software hosted in the cloud.
For more detailed analysis, ValueRay offers comprehensive research on companies like monday.com.
Piotroski VR‑10 (Strict, 0-10) 7.0
| Net Income: 118.7m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.15 > 0.02 and ΔFCF/TA -2.34 > 1.0 |
| NWC/Revenue: 87.19% < 20% (prev 98.42%; Δ -11.23% < -1%) |
| CFO/TA 0.16 > 3% & CFO 341.4m > Net Income 118.7m |
| Net Debt (-1.19b) to EBITDA (73.2m): -16.28 < 3 |
| Current Ratio: 2.50 > 1.5 & < 3 |
| Outstanding Shares: last quarter (52.9m) vs 12m ago 0.97% < -2% |
| Gross Margin: 89.20% > 18% (prev 0.89%; Δ 8830 % > 0.5%) |
| Asset Turnover: 64.98% > 50% (prev 57.67%; Δ 7.31% > 0%) |
| Interest Coverage Ratio: 1024 > 6 (EBITDA TTM 73.2m / Interest Expense TTM 58.0k) |
Altman Z'' 4.41
| A: 0.51 (Total Current Assets 1.79b - Total Current Liabilities 714.9m) / Total Assets 2.11b |
| B: -0.21 (Retained Earnings -433.3m / Total Assets 2.11b) |
| C: 0.03 (EBIT TTM 59.4m / Avg Total Assets 1.90b) |
| D: 1.45 (Book Value of Equity 1.25b / Total Liabilities 859.8m) |
| Altman-Z'' Score: 4.41 = AA |
Beneish M -0.54
| DSRI: 0.75 (Receivables 30.6m/32.3m, Revenue 1.23b/972.0m) |
| GMI: 1.00 (GM 89.20% / 89.33%) |
| AQI: 5.39 (AQ_t 0.05 / AQ_t-1 0.01) |
| SGI: 1.27 (Revenue 1.23b / 972.0m) |
| TATA: -0.11 (NI 118.7m - CFO 341.4m) / TA 2.11b) |
| Beneish M-Score: -0.54 (Cap -4..+1) = D |
What is the price of MNDY shares?
As of March 06, 2026, the stock is trading at USD 78.48 with a total of 1,851,924 shares traded.
Over the past week, the price has changed by +3.81%, over one month by -17.03%, over three months by -49.99% and over the past year by -71.99%.
Over the past week, the price has changed by +3.81%, over one month by -17.03%, over three months by -49.99% and over the past year by -71.99%.
Is MNDY a buy, sell or hold?
Monday.Com has received a consensus analysts rating of 4.48.
Therefore, it is recommended to buy MNDY.
- StrongBuy: 16
- Buy: 8
- Hold: 3
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the MNDY price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 128 | 63% |
| Analysts Target Price | 128 | 63% |
MNDY Fundamental Data Overview March 05, 2026
P/E Trailing = 32.8393
P/E Forward = 15.2905
P/S = 3.078
P/B = 2.938
P/EG = 0.2648
Revenue TTM = 1.23b USD
EBIT TTM = 59.4m USD
EBITDA TTM = 73.2m USD
Long Term Debt = 285.9m USD (estimated: total debt 311.7m - short term 25.8m)
Short Term Debt = 25.8m USD (from shortTermDebt, last quarter)
Debt = 311.7m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -1.19b USD (from netDebt column, last quarter)
Enterprise Value = 2.44b USD (3.79b + Debt 311.7m - CCE 1.67b)
Interest Coverage Ratio = 1024 (Ebit TTM 59.4m / Interest Expense TTM 58.0k)
EV/FCF = 7.61x (Enterprise Value 2.44b / FCF TTM 320.5m)
FCF Yield = 13.14% (FCF TTM 320.5m / Enterprise Value 2.44b)
FCF Margin = 26.02% (FCF TTM 320.5m / Revenue TTM 1.23b)
Net Margin = 9.64% (Net Income TTM 118.7m / Revenue TTM 1.23b)
Gross Margin = 89.20% ((Revenue TTM 1.23b - Cost of Revenue TTM 133.1m) / Revenue TTM)
Gross Margin QoQ = 88.82% (prev 88.71%)
Tobins Q-Ratio = 1.16 (Enterprise Value 2.44b / Total Assets 2.11b)
Interest Expense / Debt = 0.12% (Interest Expense 361.0k / Debt 311.7m)
Taxrate = 21.0% (US default 21%)
NOPAT = 46.9m (EBIT 59.4m * (1 - 21.00%))
Current Ratio = 2.50 (Total Current Assets 1.79b / Total Current Liabilities 714.9m)
Debt / Equity = 0.25 (Debt 311.7m / totalStockholderEquity, last quarter 1.25b)
Debt / EBITDA = -16.28 (Net Debt -1.19b / EBITDA 73.2m)
Debt / FCF = -3.72 (Net Debt -1.19b / FCF TTM 320.5m)
Total Stockholder Equity = 1.20b (last 4 quarters mean from totalStockholderEquity)
RoA = 6.26% (Net Income 118.7m / Total Assets 2.11b)
RoE = 9.88% (Net Income TTM 118.7m / Total Stockholder Equity 1.20b)
RoCE = 3.99% (EBIT 59.4m / Capital Employed (Equity 1.20b + L.T.Debt 285.9m))
RoIC = 3.95% (NOPAT 46.9m / Invested Capital 1.19b)
WACC = 12.95% (E(3.79b)/V(4.10b) * Re(14.01%) + D(311.7m)/V(4.10b) * Rd(0.12%) * (1-Tc(0.21)))
Discount Rate = 14.01% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 1.27%
[DCF] Terminal Value 66.49% ; FCFF base≈310.6m ; Y1≈376.6m ; Y5≈616.0m
[DCF] Fair Price = 123.2 (EV 5.16b - Net Debt -1.19b = Equity 6.35b / Shares 51.6m; r=12.95% [WACC]; 5y FCF grow 22.68% → 2.90% )
EPS Correlation: 75.49 | EPS CAGR: 154.1% | SUE: 0.55 | # QB: 0
Revenue Correlation: 99.12 | Revenue CAGR: 34.95% | SUE: 4.0 | # QB: 15
EPS next Quarter (2026-06-30): EPS=0.98 | Chg7d=-0.003 | Chg30d=-0.214 | Revisions Net=-19 | Analysts=23
EPS current Year (2026-12-31): EPS=4.05 | Chg7d=-0.012 | Chg30d=-0.821 | Revisions Net=-21 | Growth EPS=-7.9% | Growth Revenue=+18.4%
EPS next Year (2027-12-31): EPS=5.03 | Chg7d=-0.028 | Chg30d=-1.074 | Revisions Net=-16 | Growth EPS=+24.2% | Growth Revenue=+17.4%
[Analyst] Revisions Ratio: -0.90 (1 Up / 20 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 11.0% (Discount Rate 14.0% - Earnings Yield 3.0%)
[Growth] Growth Spread = +7.5% (Analyst 18.5% - Implied 11.0%)
P/E Forward = 15.2905
P/S = 3.078
P/B = 2.938
P/EG = 0.2648
Revenue TTM = 1.23b USD
EBIT TTM = 59.4m USD
EBITDA TTM = 73.2m USD
Long Term Debt = 285.9m USD (estimated: total debt 311.7m - short term 25.8m)
Short Term Debt = 25.8m USD (from shortTermDebt, last quarter)
Debt = 311.7m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -1.19b USD (from netDebt column, last quarter)
Enterprise Value = 2.44b USD (3.79b + Debt 311.7m - CCE 1.67b)
Interest Coverage Ratio = 1024 (Ebit TTM 59.4m / Interest Expense TTM 58.0k)
EV/FCF = 7.61x (Enterprise Value 2.44b / FCF TTM 320.5m)
FCF Yield = 13.14% (FCF TTM 320.5m / Enterprise Value 2.44b)
FCF Margin = 26.02% (FCF TTM 320.5m / Revenue TTM 1.23b)
Net Margin = 9.64% (Net Income TTM 118.7m / Revenue TTM 1.23b)
Gross Margin = 89.20% ((Revenue TTM 1.23b - Cost of Revenue TTM 133.1m) / Revenue TTM)
Gross Margin QoQ = 88.82% (prev 88.71%)
Tobins Q-Ratio = 1.16 (Enterprise Value 2.44b / Total Assets 2.11b)
Interest Expense / Debt = 0.12% (Interest Expense 361.0k / Debt 311.7m)
Taxrate = 21.0% (US default 21%)
NOPAT = 46.9m (EBIT 59.4m * (1 - 21.00%))
Current Ratio = 2.50 (Total Current Assets 1.79b / Total Current Liabilities 714.9m)
Debt / Equity = 0.25 (Debt 311.7m / totalStockholderEquity, last quarter 1.25b)
Debt / EBITDA = -16.28 (Net Debt -1.19b / EBITDA 73.2m)
Debt / FCF = -3.72 (Net Debt -1.19b / FCF TTM 320.5m)
Total Stockholder Equity = 1.20b (last 4 quarters mean from totalStockholderEquity)
RoA = 6.26% (Net Income 118.7m / Total Assets 2.11b)
RoE = 9.88% (Net Income TTM 118.7m / Total Stockholder Equity 1.20b)
RoCE = 3.99% (EBIT 59.4m / Capital Employed (Equity 1.20b + L.T.Debt 285.9m))
RoIC = 3.95% (NOPAT 46.9m / Invested Capital 1.19b)
WACC = 12.95% (E(3.79b)/V(4.10b) * Re(14.01%) + D(311.7m)/V(4.10b) * Rd(0.12%) * (1-Tc(0.21)))
Discount Rate = 14.01% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 1.27%
[DCF] Terminal Value 66.49% ; FCFF base≈310.6m ; Y1≈376.6m ; Y5≈616.0m
[DCF] Fair Price = 123.2 (EV 5.16b - Net Debt -1.19b = Equity 6.35b / Shares 51.6m; r=12.95% [WACC]; 5y FCF grow 22.68% → 2.90% )
EPS Correlation: 75.49 | EPS CAGR: 154.1% | SUE: 0.55 | # QB: 0
Revenue Correlation: 99.12 | Revenue CAGR: 34.95% | SUE: 4.0 | # QB: 15
EPS next Quarter (2026-06-30): EPS=0.98 | Chg7d=-0.003 | Chg30d=-0.214 | Revisions Net=-19 | Analysts=23
EPS current Year (2026-12-31): EPS=4.05 | Chg7d=-0.012 | Chg30d=-0.821 | Revisions Net=-21 | Growth EPS=-7.9% | Growth Revenue=+18.4%
EPS next Year (2027-12-31): EPS=5.03 | Chg7d=-0.028 | Chg30d=-1.074 | Revisions Net=-16 | Growth EPS=+24.2% | Growth Revenue=+17.4%
[Analyst] Revisions Ratio: -0.90 (1 Up / 20 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 11.0% (Discount Rate 14.0% - Earnings Yield 3.0%)
[Growth] Growth Spread = +7.5% (Analyst 18.5% - Implied 11.0%)